using platelet aggregometry , we investigated the in vitro efficacy of dextran , mean mw 40,000 , in reducing the heparin-mediated platelet aggregation seen with the syndrome of heparin-associated thrombocytopenia ( hat ) .
C0086140
dextran
C0040034
thrombocytopenia